PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
R. alba essential oil showed the highest inhibitory activity among tested Bulgarian roses across different phylogenetic strains, with MICs ranging from 0.16-0.31 mg/mL [PMID:39598517]
R. alba essential oil does not affect viral replication but can influence viral adsorption and extracellular virions, protecting healthy cells from infection; it demonstrates enhanced activity when used in combination with lower doses of acyclovir [PMID:34439978]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 33478154 (2021) — Rose Flowers-A Delicate Perfume or a Natural Healer? · Biomolecules
- 2.PMID: 40479219 (2022) — Functional Compounds and Antioxidant Activity of Rosa Species Grown In Turkey. · Erwerbs-Obstbau
- 3.PMID: 39598517 (2024) — Antimycobacterial Activity of Essential Oils from Bulgarian Rosa Species Against Phylogenomically Different Mycobacterium tuberculosis Strains. · Pharmaceutics
- 4.PMID: 34439978 (2021) — Antiviral Activity of Rosa damascena Mill. and Rosa alba L. Essential Oils against the Multiplication of Herpes Simplex Virus Type 1 Strains Sensitive and Resistant to Acyclovir. · Biology
- 5.PMID: 36143488 (2022) — Study on Cytotoxic and Genotoxic Potential of Bulgarian Rosa damascena Mill. and Rosa alba L. Hydrosols-In Vivo and In Vitro.